Mirae Asset Global Investments’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.68M | Buy |
7,351
+410
| +6% | +$91.9K | ﹤0.01% | 774 |
|
|
2025
Q4 | $1.48M | Buy |
6,941
+860
| +14% | +$178K | ﹤0.01% | 837 |
|
|
2025
Q3 | $1.21M | Buy |
6,081
+58
| +1% | +$10.8K | ﹤0.01% | 859 |
|
|
2025
Q2 | $1.04M | Sell |
6,023
-1,062
| -15% | -$173K | ﹤0.01% | 824 |
|
|
2025
Q1 | $1.1M | Buy |
7,085
+11
| +0.2% | +$1.57K | ﹤0.01% | 796 |
|
|
2024
Q4 | $968K | Sell |
7,074
-67
| -0.9% | -$8.81K | ﹤0.01% | 828 |
|
|
2024
Q3 | $1.03M | Sell |
7,141
-1,075
| -13% | -$145K | ﹤0.01% | 810 |
|
|
2024
Q2 | $1.11M | Sell |
8,216
-5,060
| -38% | -$688K | 0.01% | 728 |
|
|
2024
Q1 | $1.74M | Sell |
13,276
-713
| -5% | -$102K | ﹤0.01% | 1265 |
|
|
2023
Q4 | $1.76M | Buy |
13,989
+186
| +1% | +$18.5K | ﹤0.01% | 1317 |
|
|
2023
Q3 | $1.29M | Buy |
13,803
+921
| +7% | +$86.2K | ﹤0.01% | 1399 |
|
|
2023
Q2 | $1.15M | Sell |
12,882
-4,005
| -24% | -$349K | ﹤0.01% | 1486 |
|
|
2023
Q1 | $1.81M | Sell |
16,887
-2,847
| -14% | -$326K | ﹤0.01% | 1259 |
|
|
2022
Q4 | $2.41M | Sell |
19,734
-3,755
| -16% | -$436K | 0.01% | 1062 |
|
|
2022
Q3 | $2.42M | Sell |
23,489
-5,995
| -20% | -$568K | 0.01% | 1059 |
|
|
2022
Q2 | $2.74M | Buy |
29,484
+1,237
| +4% | +$117K | 0.01% | 1042 |
|
|
2022
Q1 | $3.31M | Sell |
28,247
-1,041
| -4% | -$121K | 0.01% | 1009 |
|
|
2021
Q4 | $3.94M | Sell |
29,288
-368
| -1% | -$54.7K | 0.01% | 946 |
|
|
2021
Q3 | $4.73M | Buy |
29,656
+418
| +1% | +$57.2K | 0.01% | 855 |
|
|
2021
Q2 | $3.85M | Sell |
29,238
-2,548
| -8% | -$340K | 0.01% | 883 |
|
|
2021
Q1 | $4.1M | Buy |
31,786
+6,468
| +26% | +$983K | 0.01% | 774 |
|
|
2020
Q4 | $4.22M | Buy |
25,318
+183
| +0.7% | +$30.3K | 0.02% | 693 |
|
|
2020
Q3 | $3.88M | Buy |
25,135
+4,973
| +25% | +$715K | 0.02% | 602 |
|
|
2020
Q2 | $2.98M | Sell |
20,162
-1,236
| -6% | -$170K | 0.02% | 609 |
|
|
2020
Q1 | $2.41M | Buy |
21,398
+3,813
| +22% | +$495K | 0.02% | 593 |
|
|
2019
Q4 | $2.45M | Buy |
17,585
+6,072
| +53% | +$675K | 0.02% | 690 |
|
|
2019
Q3 | $1.11M | Sell |
11,513
-103
| -0.9% | -$11.5K | 0.01% | 883 |
|
|
2019
Q2 | $1.34M | Sell |
11,616
-1,935
| -14% | -$232K | 0.01% | 825 |
|
|
2019
Q1 | $1.59M | Buy |
13,551
+2,257
| +20% | +$198K | 0.01% | 695 |
|
|
2018
Q4 | $708K | Buy |
11,294
+2,850
| +34% | +$179K | 0.01% | 882 |
|
|
2018
Q3 | $598K | Buy |
8,444
+5,107
| +153% | +$352K | ﹤0.01% | 987 |
|
|
2018
Q2 | $222K | Buy |
3,337
+31
| +0.9% | +$2.04K | ﹤0.01% | 743 |
|
|
2018
Q1 | $216K | Buy |
+3,306
| New | +$186K | ﹤0.01% | 698 |
|
Other funds holding ASND
RCM
ACA
